Glaxo Forks Over $70M in Drug-Pricing Fraud

Law360, New York (August 10, 2006, 12:00 AM EDT) -- GlaxoSmithKline PLC has agreed to shell out an estimated $70 million to put to rest claims that the pharmaceutical giant artificially inflated the prices of various drugs, including cancer medications.

The company announced the nationwide class-action settlement on Thursday, marking the end of the consolidated Boston litigation over GlaxoSmithKline’s Average Wholesale Price of various medicines.

The health care goliath also revealed a deal over claims filed by the attorney generals of New York, California, Connecticut, Nevada, Montana and Arizona, as well as potential claims by 34...
To view the full article, register now.